Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thromboxane A2 receptor | Starlite/ChEMBL | No references |
Rattus norvegicus | Thromboxane A2 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | opsin-like receptor | Thromboxane A2 receptor | 341 aa | 313 aa | 22.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | calpain | 0.0062 | 0.0503 | 0.0503 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0412 | 1 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0062 | 0.0503 | 0.0503 |
Brugia malayi | calpain family protein 1 | 0.0163 | 0.3263 | 0.3263 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0163 | 0.3263 | 0.3263 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.0503 |
Toxoplasma gondii | cathepsin B | 0.0136 | 0.2517 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0163 | 0.3263 | 0.3263 |
Echinococcus multilocularis | cathepsin b | 0.0412 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0412 | 1 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.012 | 0.2094 | 0.2094 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.1997 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.0503 |
Entamoeba histolytica | calpain large subunit domain III containing protein | 0.0043 | 0 | 0.5 |
Echinococcus multilocularis | cathepsin b | 0.0412 | 1 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0136 | 0.2517 | 0.5 |
Entamoeba histolytica | protein kinase, putative | 0.0043 | 0 | 0.5 |
Echinococcus granulosus | calpain A | 0.0171 | 0.3464 | 0.3118 |
Trypanosoma brucei | calpain-like protein, putative | 0.0062 | 0.0503 | 0.1997 |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0136 | 0.2517 | 1 |
Brugia malayi | calpain family protein 1 | 0.0163 | 0.3263 | 0.3263 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0163 | 0.3263 | 0.2906 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.0503 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0412 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.1591 | 0.1591 |
Loa Loa (eye worm) | hypothetical protein | 0.0145 | 0.276 | 0.276 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.1997 |
Echinococcus multilocularis | calpain A | 0.0171 | 0.3464 | 0.3118 |
Trypanosoma brucei | calpain-like protein, putative | 0.0062 | 0.0503 | 0.1997 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0412 | 1 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0171 | 0.3464 | 0.3118 |
Echinococcus granulosus | cathepsin b | 0.0412 | 1 | 1 |
Loa Loa (eye worm) | cathepsin B | 0.0136 | 0.2517 | 0.2517 |
Giardia lamblia | Cathepsin B precursor | 0.0136 | 0.2517 | 0.5 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0136 | 0.2517 | 0.5 |
Plasmodium vivax | calpain, putative | 0.0062 | 0.0503 | 0.5 |
Echinococcus granulosus | cathepsin b | 0.0412 | 1 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0412 | 1 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0062 | 0.0503 | 0.0503 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0412 | 1 | 1 |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 0.0136 | 0.2517 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0062 | 0.0503 | 0.0503 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0062 | 0.0503 | 0.0503 |
Trypanosoma brucei | antigen, putative | 0.0062 | 0.0503 | 0.1997 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0171 | 0.3464 | 0.3118 |
Brugia malayi | calpain 7 | 0.0062 | 0.0503 | 0.0503 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0136 | 0.2517 | 0.2517 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0062 | 0.0503 | 0.1997 |
Onchocerca volvulus | 0.0102 | 0.1591 | 0.5 | |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0062 | 0.0503 | 0.0503 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0062 | 0.0503 | 0.0503 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0171 | 0.3464 | 0.3118 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0171 | 0.3464 | 0.3118 |
Leishmania major | calpain, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.1997 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.1997 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.2094 | 0.2094 |
Echinococcus multilocularis | calpain family protein 1, d | 0.012 | 0.2094 | 0.1675 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0136 | 0.2517 | 0.2121 |
Trypanosoma brucei | calpain-like protein, putative | 0.0062 | 0.0503 | 0.1997 |
Trypanosoma brucei | calpain-like protein, putative | 0.0062 | 0.0503 | 0.1997 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0062 | 0.0503 | 0.0503 |
Giardia lamblia | Cathepsin B precursor | 0.0136 | 0.2517 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (functional) | = 7.9 | In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip | ChEMBL. | No reference |
Kd (functional) | = 8.1 | In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood | ChEMBL. | No reference |
pA2 (functional) | = 7.9 | In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip | ChEMBL. | No reference |
pA2 (functional) | = 8.1 | In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.